Article

Draft Guidance of Lists of Retail Consignees Issued by FDA for Food Recalls

Author(s):

The new document will provide guidance on how and when the FDA intends to collect, compile, and publicize retail consignees that may have received recalled foods.

TB — Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models) Recalled

Not sure what’s been recalled, withdrawn from the market, or had safety updates? Catch up on the US Food and Drug Administration’s (FDA’s) recalls and market withdrawals from this past week. Oscor Inc. is issuing a recall of TB - Temporary Bipolar Pacing Leads featuring the 2mm unshrouded connectors due to possible malfunction with the connector cap housing (see Picture 1, No. 2 Pin Cap and Cover), which may interrupt the pacing system.

A design change of the cap housing of the pins was attributed for the device failures from analyses of the returned devices, which may cause the connectors to separate during use.

Four serious injuries attributed a connector cap malfunction were reported in the last 6 years. While no deaths have been reported, the risk for possible injury is a concern

Draft Guidance of Lists of Retail Consignees Issued by FDA for Food Recalls

For more information on this recall, check out the FDA’s statement. The FDA has announced the availability of draft guidance entitled “Public Availability of Lists of Retail Consignees to Effectuate Certain Human and Animal Food Recalls” for industry and FDA staff regarding food recalls.

The new document will provide guidance on how and when the FDA intends to collect, compile, and publicize retail consignees that may have received recalled foods.

The guidance will also allow the FDA to publicize retail consignee lists for other food recalls provided the food will cause serious adverse health consequences or death to humans or animals (Class I recalls).

With the guidance, the FDA will aim to publicize retail consignee lists for these food recalls to help consumers quickly and effectively identify recalled food and determine whether that food is in their possession.

For more information on this draft guidance, check out the FDA’s statement.

Related Videos
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
Will Herrington, MBBS, MD, MA: Empagliflozin Follow-up Data Informs Clinical Care for CKD
Jennifer Lai Yee, MD, PhD, MPH: Honing in on Sparsentan’s Benefit in Genetic FSGS
Highlighting Recent Therapies for Dermatologists, with James Del Rosso, DO
Ladan Zand, MD: Obinutuzumab Promising Option for Refractory, Primary FSGS
Rahul N. Khurana, MD: Phase 1 Results on Vamikibart for Uveitic Macular Edema | Image Credit: Northern California Retina Vitreous Associates
Sunir J. Garg, MD: | Image Credit: Wills Eye Hospital
James Del Rosso, DO: Discussing What’s New in the Medicine Chest for Dermatologists
© 2024 MJH Life Sciences

All rights reserved.